Pannuti F - Search Results

1

Activity of 4-demethoxydaunorubicin by the oral route in advanced breast cancer.

Martoni A, Pacciarini MA, Pannuti F. Martoni A, et al. Among authors: pannuti f. Eur J Cancer Clin Oncol. 1985 Jul;21(7):803-6. doi: 10.1016/0277-5379(85)90218-4. Eur J Cancer Clin Oncol. 1985. PMID: 3862582

2

Adjuvant therapy for operable breast cancer with medroxyprogesterone acetate alone in postmenopausal patients or in combination with CMF in premenopausal patients.

Pannuti F, Martoni A, Cilenti G, Camaggi CM, Fruet F. Pannuti F, et al. Eur J Cancer Clin Oncol. 1988 Mar;24(3):423-9. doi: 10.1016/s0277-5379(98)90012-8. Eur J Cancer Clin Oncol. 1988. PMID: 2968262 Clinical Trial.

3

Low dose oral administration of 4-demethoxydaunorubicin (idarubicin) in advanced cancer patients. A pharmacokinetic study.

Pannuti F, Camaggi CM, Strocchi E, Comparsi R, Angelelli B, Pacciarini MA. Pannuti F, et al. Cancer Chemother Pharmacol. 1986;16(3):295-9. doi: 10.1007/BF00293996. Cancer Chemother Pharmacol. 1986. PMID: 3457647

4

The new anthracycline 4-demethoxydaunorubicin by oral route in advanced pretreated breast cancer and melanoma. A pilot study.

Martoni A, Pacciarini MA, Pannuti F. Martoni A, et al. Among authors: pannuti f. Drugs Exp Clin Res. 1985;11(2):127-31. Drugs Exp Clin Res. 1985. PMID: 3915281 Clinical Trial.

5

High-dose medroxyprogesterone acetate versus oophorectomy as first-line therapy of advanced breast cancer in premenopausal patients.

Martoni A, Longhi A, Canova N, Pannuti F. Martoni A, et al. Among authors: pannuti f. Oncology. 1991;48(1):1-6. doi: 10.1159/000226884. Oncology. 1991. PMID: 1824798 Clinical Trial.

6

Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancer.

Pannuti F, Martoni A, Di Marco AR, Piana E, Saccani F, Becchi G, Mattioli G, Barbanti F, Marra GA, Persiani W, Cacciari L, Spagnolo F, Palenzona D, Rocchetta G. Pannuti F, et al. Eur J Cancer (1965). 1979 Apr;15(4):593-601. doi: 10.1016/0014-2964(79)90097-5. Eur J Cancer (1965). 1979. PMID: 86447 Clinical Trial. No abstract available.

7

A possible new approach to the treatment of metastatic breast cancer: massive doses of medroxyprogesterone acetate.

Pannuti F, Martoni A, Lenaz GR, Piana E, Nanni P. Pannuti F, et al. Cancer Treat Rep. 1978 Apr;62(4):499-504. Cancer Treat Rep. 1978. PMID: 350387 Clinical Trial.

8

A phase II study of high-dose epirubicin plus cisplatinum in advanced non-small-cell lung cancer (NSCLC).

Martoni A, Guaraldi M, Casadio M, Busutti L, Pannuti F. Martoni A, et al. Among authors: pannuti f. Ann Oncol. 1992 Dec;3(10):864-6. doi: 10.1093/oxfordjournals.annonc.a058114. Ann Oncol. 1992. PMID: 1337467 Free article. Clinical Trial.

9

Idarubicin metabolism and pharmacokinetics after intravenous and oral administration in cancer patients: a crossover study.

Camaggi CM, Strocchi E, Carisi P, Martoni A, Tononi A, Guaraldi M, Strolin-Benedetti M, Efthymiopoulos C, Pannuti F. Camaggi CM, et al. Among authors: pannuti f. Cancer Chemother Pharmacol. 1992;30(4):307-16. doi: 10.1007/BF00686301. Cancer Chemother Pharmacol. 1992. PMID: 1643700 Clinical Trial.

10

Activity of high-dose epirubicin in advanced non-small cell lung cancer.

Martoni A, Melotti B, Guaraldi M, Pannuti F. Martoni A, et al. Among authors: pannuti f. Eur J Cancer. 1991;27(10):1231-4. doi: 10.1016/0277-5379(91)90087-t. Eur J Cancer. 1991. PMID: 1659841 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters